C the Signs

C the Signs develops an AI platform for early cancer detection. Its clinician tool integrates into existing electronic health record systems and draws on more than 1,000 validated signs, symptoms and risk factors to recommend investigations or referrals in under 60 seconds. A patient-facing risk assessment lets people check their cancer risk and, in some cases, be booked into diagnostic tests without first seeing a doctor.

The stated customers are clinicians in primary care and health systems, and the website cites use at Somerset NHS Foundation Trust and by a GP practice. The website does not describe its pricing or revenue model. It also describes population-level scanning of clinical data to identify at-risk patients before they are suspected of having cancer.

The company was co-founded by Dr Bhavagaya Bakshi (CEO) and Dr Miles Payling (Chief Scientific Officer), who started it within the NHS. The website lists a Chief Technology Officer and a team of engineers, data scientists and clinical staff, and cites peer-reviewed studies and research abstracts. Open roles listed include senior machine learning, MLOps, AI data engineering and design positions, mostly remote in the US and UK. The founding year, headquarters and office locations are not stated on the website.

Product: AI cancer risk assessment platform embedded in electronic health records for clinicians, plus a patient self-assessment for risk checks and diagnostic booking.